Merck & Co’s asthma drug Singulair faces US generic onslaught – PMLiVE


MedPage Today

Merck & Co's asthma drug Singulair faces US generic onslaught
PMLiVE
The Food and Drug Administration (FDA) has approved the first generic versions of Merck & Co's blockbuster asthma and allergy drug Singulair. The US regulator granted ten companies licences to market their own version of Singulair (motelukast) for use
Israel : TEVA bags approval from FDA to market generic asthma treatment Equities.com
New generic Singulair could save asthma sufferers big bucksConsumerReports.org
Generic Singulair ApprovedWebMD
MedPage Today –Drug Store News –FDA.gov
all 54 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.